Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “RA PHARMACEUTICALS, INC.”

115 pharma patents match "RA PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 115
Index total 30,257
Page 3 / 5

Quick answer

This filtered view shows 115 pharmaceutical patents matching "RA PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

115 results for “RA PHARMACEUTICALS, INC.” · 30,257 patents in full index Clear search

  1. US 10954287

    Ras binding peptides and methods of use

    RA PHARMACEUTICALS, INC. · Granted Mar 23, 2021 · Expires Mar 18, 2041

    granted

  2. US 10918691

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Feb 16, 2021 · Expires Feb 11, 2041

    granted

  3. US 10835574

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Nov 17, 2020 · Expires Nov 12, 2040

    granted

  4. US 10729651

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  5. US 10709665

    Zinc meloxicam complex microparticle multivesicular liposome formulations and processes for making the same

    Pacira Pharmaceuticals, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  6. US 10675245

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  7. US 10617642

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted

  8. US 10610486

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Apr 7, 2020 · Expires Apr 2, 2040

    granted

  9. US 10588936

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted

  10. US 10562934

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  11. US 10435438

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Oct 8, 2019 · Expires Oct 3, 2039

    granted

  12. US 10398648

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  13. US 10328115

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  14. US 10272132

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  15. US 10208089

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

  16. US 10123974

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  17. US 10106579

    Modulation of complement activity

    RA PHARMACEUTICALS, INC. · Granted Oct 23, 2018 · Expires Oct 18, 2038

    granted

  18. US 10045941

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  19. US 10028911

    Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (DMARD) and an anti-cancer agent

    Pacira Pharmaceuticals, Inc. · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  20. US 10000456

    Polycyclic compounds as lysophosphatidic acid receptor antagonists

    AMIRA PHARMACEUTICALS, INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  21. US 9999650

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  22. US 9974744

    Sustained release formulation of a non-steroidal anti-inflammatory drug

    Pacira Pharmaceuticals, Inc. · Granted May 22, 2018 · Expires May 17, 2038

    granted

  23. US 9937222

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  24. US 9849109

    Autotaxin inhibitors and uses thereof

    AMIRA PHARMACEUTICALS, INC. · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.